United States Recombinant Proteins Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Recombinant Proteins Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Recombinant Proteins Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Recombinant Proteins Overall Market Size
2.1 United States Recombinant Proteins Market Size: 2021 VS 2027
2.2 United States Recombinant Proteins Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Proteins Players in United States Market
3.2 Top United States Recombinant Proteins Companies Ranked by Revenue
3.3 United States Recombinant Proteins Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Proteins Companies in United States Market, by Revenue in 2020
3.5 Companies Recombinant Proteins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Proteins Players in United States Market
3.6.1 List of Tier 1 Recombinant Proteins Companies in United States
3.6.2 List of Tier 2 and Tier 3 Recombinant Proteins Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Recombinant Proteins Market Size Markets, 2021 & 2027
4.1.2 Hormones
4.1.3 Growth Factors
4.1.4 Cytokines
4.1.5 Plasma Protein Factor
4.1.6 Recombinant Metabolic Enzymes
4.1.7 Immune Checkpoint Regulators
4.1.8 Others
4.2 By Type - United States Recombinant Proteins Revenue & Forecasts
4.2.1 By Type - United States Recombinant Proteins Revenue, 2016-2021
4.2.2 By Type - United States Recombinant Proteins Revenue, 2022-2027
4.2.3 By Type - United States Recombinant Proteins Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Recombinant Proteins Market Size, 2021 & 2027
5.1.2 Biopharmaceutical Companies
5.1.3 Academic and Research Institutes
5.1.4 Contract Research Organizations
5.2 By Application - United States Recombinant Proteins Revenue & Forecasts
5.2.1 By Application - United States Recombinant Proteins Revenue, 2016-2021
5.2.2 By Application - United States Recombinant Proteins Revenue, 2022-2027
5.2.3 By Application - United States Recombinant Proteins Revenue Market Share, 2016-2027
6 Recombinant Proteins Companies Profiles
6.1 Abcam PLC
6.1.1 Abcam PLC Company Details
6.1.2 Abcam PLC Business Overview
6.1.3 Abcam PLC Recombinant Proteins Introduction
6.1.4 Abcam PLC Recombinant Proteins Revenue in United States Market (2016-2021)
6.1.5 Abcam PLC Recent Developments
6.2 R&D Systems
6.2.1 R&D Systems Company Details
6.2.2 R&D Systems Business Overview
6.2.3 R&D Systems Recombinant Proteins Introduction
6.2.4 R&D Systems Recombinant Proteins Revenue in United States Market (2016-2021)
6.2.5 R&D Systems Recent Developments
6.3 Miltenyi Biotec
6.3.1 Miltenyi Biotec Company Details
6.3.2 Miltenyi Biotec Business Overview
6.3.3 Miltenyi Biotec Recombinant Proteins Introduction
6.3.4 Miltenyi Biotec Recombinant Proteins Revenue in United States Market (2016-2021)
6.3.5 Miltenyi Biotec Recent Developments
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Details
6.4.2 Thermo Fisher Scientific Business Overview
6.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction
6.4.4 Thermo Fisher Scientific Recombinant Proteins Revenue in United States Market (2016-2021)
6.4.5 Thermo Fisher Scientific Recent Developments
6.5 Sigma Aldrich Company
6.5.1 Sigma Aldrich Company Company Details
6.5.2 Sigma Aldrich Company Business Overview
6.5.3 Sigma Aldrich Company Recombinant Proteins Introduction
6.5.4 Sigma Aldrich Company Recombinant Proteins Revenue in United States Market (2016-2021)
6.5.5 Sigma Aldrich Company Recent Developments
6.6 GE Healthcare
6.6.1 GE Healthcare Company Details
6.6.2 GE Healthcare Business Overview
6.6.3 GE Healthcare Recombinant Proteins Introduction
6.6.4 GE Healthcare Recombinant Proteins Revenue in United States Market (2016-2021)
6.6.5 GE Healthcare Recent Developments
6.7 Lonza
6.7.1 Lonza Company Details
6.7.2 Lonza Business Overview
6.7.3 Lonza Recombinant Proteins Introduction
6.7.4 Lonza Recombinant Proteins Revenue in United States Market (2016-2021)
6.7.5 Lonza Recent Developments
6.8 Merck KGaA
6.8.1 Merck KGaA Company Details
6.8.2 Merck KGaA Business Overview
6.8.3 Merck KGaA Recombinant Proteins Introduction
6.8.4 Merck KGaA Recombinant Proteins Revenue in United States Market (2016-2021)
6.8.5 Merck KGaA Recent Developments
6.9 ProSpec Tany TechnoGene
6.9.1 ProSpec Tany TechnoGene Company Details
6.9.2 ProSpec Tany TechnoGene Business Overview
6.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
6.9.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue in United States Market (2016-2021)
6.9.5 ProSpec Tany TechnoGene Recent Developments
6.10 Eurogentec (Kaneka Corporation)
6.10.1 Eurogentec (Kaneka Corporation) Company Details
6.10.2 Eurogentec (Kaneka Corporation) Business Overview
6.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction
6.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue in United States Market (2016-2021)
6.10.5 Eurogentec (Kaneka Corporation) Recent Developments
6.11 PeproTech
6.11.1 PeproTech Company Details
6.11.2 PeproTech Business Overview
6.11.3 PeproTech Recombinant Proteins Introduction
6.11.4 PeproTech Recombinant Proteins Revenue in United States Market (2016-2021)
6.11.5 PeproTech Recent Developments
6.12 BPS Bioscience
6.12.1 BPS Bioscience Company Details
6.12.2 BPS Bioscience Business Overview
6.12.3 BPS Bioscience Recombinant Proteins Introduction
6.12.4 BPS Bioscience Recombinant Proteins Revenue in United States Market (2016-2021)
6.12.5 BPS Bioscience Recent Developments
6.13 Reprocell
6.13.1 Reprocell Company Details
6.13.2 Reprocell Business Overview
6.13.3 Reprocell Recombinant Proteins Introduction
6.13.4 Reprocell Recombinant Proteins Revenue in United States Market (2016-2021)
6.13.5 Reprocell Recent Developments
6.14 GenScript Biotech Corporation
6.14.1 GenScript Biotech Corporation Company Details
6.14.2 GenScript Biotech Corporation Business Overview
6.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction
6.14.4 GenScript Biotech Corporation Recombinant Proteins Revenue in United States Market (2016-2021)
6.14.5 GenScript Biotech Corporation Recent Developments
6.15 Abnova Corporation
6.15.1 Abnova Corporation Company Details
6.15.2 Abnova Corporation Business Overview
6.15.3 Abnova Corporation Recombinant Proteins Introduction
6.15.4 Abnova Corporation Recombinant Proteins Revenue in United States Market (2016-2021)
6.15.5 Abnova Corporation Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Recombinant Proteins Market Opportunities & Trends in United States Market
Table 2. Recombinant Proteins Market Drivers in United States Market
Table 3. Recombinant Proteins Market Restraints in United States Market
Table 4. Key Players of Recombinant Proteins in United States Market
Table 5. Top Recombinant Proteins Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Recombinant Proteins Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Recombinant Proteins Revenue Share by Companies, 2016-2021
Table 8. Companies Recombinant Proteins Product Type
Table 9. List of Tier 1 Recombinant Proteins Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Recombinant Proteins Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Recombinant Proteins Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Recombinant Proteins Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Recombinant Proteins Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Recombinant Proteins Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Recombinant Proteins Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Recombinant Proteins Revenue (US$, Mn), 2022-2027
Table 17. Abcam PLC Company Details
Table 18. Abcam PLC Business Overview
Table 19. Abcam PLC Recombinant Proteins Product
Table 20. Abcam PLC Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abcam PLC Recent Developments
Table 22. R&D Systems Company Details
Table 23. R&D Systems Business Overview
Table 24. R&D Systems Recombinant Proteins Product
Table 25. R&D Systems Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. R&D Systems Recent Developments
Table 27. Miltenyi Biotec Company Details
Table 28. Miltenyi Biotec Business Overview
Table 29. Miltenyi Biotec Recombinant Proteins Product
Table 30. Miltenyi Biotec Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Miltenyi Biotec Recent Developments
Table 32. Thermo Fisher Scientific Company Details
Table 33. Thermo Fisher Scientific Business Overview
Table 34. Thermo Fisher Scientific Recombinant Proteins Product
Table 35. Thermo Fisher Scientific Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Thermo Fisher Scientific Recent Developments
Table 37. Sigma Aldrich Company Company Details
Table 38. Sigma Aldrich Company Business Overview
Table 39. Sigma Aldrich Company Recombinant Proteins Product
Table 40. Sigma Aldrich Company Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Sigma Aldrich Company Recent Developments
Table 42. GE Healthcare Company Details
Table 43. GE Healthcare Business Overview
Table 44. GE Healthcare Recombinant Proteins Product
Table 45. GE Healthcare Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. GE Healthcare Recent Developments
Table 47. Lonza Company Details
Table 48. Lonza Business Overview
Table 49. Lonza Recombinant Proteins Product
Table 50. Lonza Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Lonza Recent Developments
Table 52. Merck KGaA Company Details
Table 53. Merck KGaA Business Overview
Table 54. Merck KGaA Recombinant Proteins Product
Table 55. Merck KGaA Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Merck KGaA Recent Developments
Table 57. ProSpec Tany TechnoGene Company Details
Table 58. ProSpec Tany TechnoGene Business Overview
Table 59. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 60. ProSpec Tany TechnoGene Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. ProSpec Tany TechnoGene Recent Developments
Table 62. Eurogentec (Kaneka Corporation) Company Details
Table 63. Eurogentec (Kaneka Corporation) Business Overview
Table 64. Eurogentec (Kaneka Corporation) Recombinant Proteins Product
Table 65. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Eurogentec (Kaneka Corporation) Recent Developments
Table 67. PeproTech Company Details
Table 68. PeproTech Business Overview
Table 69. PeproTech Recombinant Proteins Product
Table 70. PeproTech Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. PeproTech Recent Developments
Table 72. BPS Bioscience Company Details
Table 73. BPS Bioscience Business Overview
Table 74. BPS Bioscience Recombinant Proteins Product
Table 75. BPS Bioscience Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. BPS Bioscience Recent Developments
Table 77. Reprocell Company Details
Table 78. Reprocell Business Overview
Table 79. Reprocell Recombinant Proteins Product
Table 80. Reprocell Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Reprocell Recent Developments
Table 82. GenScript Biotech Corporation Company Details
Table 83. GenScript Biotech Corporation Business Overview
Table 84. GenScript Biotech Corporation Recombinant Proteins Product
Table 85. GenScript Biotech Corporation Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. GenScript Biotech Corporation Recent Developments
Table 87. Abnova Corporation Business Overview
Table 88. Abnova Corporation Company Details
Table 89. Abnova Corporation Recombinant Proteins Product
Table 90. Abnova Corporation Recombinant Proteins Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. Abnova Corporation Recent Developments
List of FiguresFigure 1. Recombinant Proteins Segment by Type
Figure 2. Recombinant Proteins Segment by Application
Figure 3. United States Recombinant Proteins Market Overview: 2020
Figure 4. United States Recombinant Proteins Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Recombinant Proteins Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Recombinant Proteins Revenue in 2020
Figure 7. By Type - United States Recombinant Proteins Revenue Market Share, 2016-2027
Figure 8. By Application - United States Recombinant Proteins Revenue Market Share, 2016-2027
Figure 9. Abcam PLC Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. R&D Systems Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Miltenyi Biotec Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Thermo Fisher Scientific Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Sigma Aldrich Company Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. GE Healthcare Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Lonza Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Merck KGaA Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. ProSpec Tany TechnoGene Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. PeproTech Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. BPS Bioscience Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Reprocell Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. GenScript Biotech Corporation Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Abnova Corporation Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2016-2021)